Stegenga accuses the FDA, which has close ties to industry, of setting the bar too low in approving drugs. He quotes a senior FDA epidemiologist complaining that the agency “consistently overrated the benefits of the drugs it approved and rejected, downplayed or ignored the safety problems.”
This seems to be a problem with science across the board, not just medicine.
No comments:
Post a Comment